Reflect Scientific Inc. develops advanced cryogenic cooling and refrigeration technologies for customers that require ultra-low-temperature storage, rapid freezing, and cold-chain support. Company news commonly covers orders and installations for B-90 blast freezers, liquid nitrogen freezer systems, and other high-performance cooling products used by pharmaceutical, biotechnology, vaccine storage, and logistics customers.
Recurring updates also address patented cryogenic cooling applications for data centers and server rooms, operating-cost initiatives, contract manufacturing relationships, and OTC market disclosure status. The company’s announcements center on product adoption, precision temperature-control use cases, and business changes tied to its cryogenic technology platform.
On July 12, 2022, Reflect Scientific (RSCF) shared a shareholder update highlighting advancements in their liquid nitrogen technology across processing, storage, and transportation sectors. The company holds 30 patents safeguarding its innovative applications. Key products include the Cryometrix brand blast freezers and solvent chillers for biotech and pharmaceutical industries. The outlook remains optimistic with ongoing R&D investments, and Reflect Scientific reports being debt-free and profitable. They are also pursuing opportunities with the California Air Resource Board.
Reflect Scientific, Inc. (RSCF) has been awarded a groundbreaking patent for a green cooling system that eliminates HCFCs and CFCs, utilizing a Cryometrix temperature control system with liquid nitrogen or liquefied air. This innovative system demonstrates cost-effectiveness in refrigeration and air conditioning applications. The CEO, Kim Boyce, highlighted a significant market opportunity, estimating a multi-trillion-dollar potential in sectors currently using HFCs, especially as the federal government pushes for sustainable alternatives to reduce greenhouse gas emissions.
Reflect Scientific, Inc. (RSCF) announced a company overview presentation on May 17, 2022. This PDF presentation includes key digital media links, product overviews, and financial information for the last five quarters, available on the company's website. CEO Kim Boyce emphasized the need for an accessible resource to inform customers and investors about the company's growth and innovations in cryogenic cooling technologies. The presentation is expected to evolve with new product launches and updated financial data.
Reflect Scientific, Inc. (RSCF) reported a significant performance boost for Q1 2022 with a 34% increase in revenue at $753,576 compared to $562,362 in Q1 2021. The company also noted a 51% increase in operational income. CEO Kim Boyce attributed this growth to a focused marketing strategy in the expanding cryogenic freezing and storage sector. Operating expenses edged up to $312,782, but net income stood at $206,505, marking a decrease from $247,768 in the previous year.
Reflect Scientific, Inc. (RSCF) reported a remarkable 4,067% increase in chiller sales for the first quarter of 2022, totaling $244,000, up from $6,000 in the same period in 2021. This growth follows the easing of COVID-19 related shutdowns. The second quarter also showcased strong performance, achieving $291,000 in sales. CEO Mr. Boyce highlighted significant product improvements based on customer feedback, contributing to the surge in demand for their Cryometrix solvent chillers, widely used in pharmaceutical and biotech industries.
Reflect Scientific, Inc. (RSCF) reported its annual 10K financial results, showing a slight revenue increase of 0.8% to $2.81 million for 2021. Gross margin improved to 69%, up from 62% the previous year, attributed to reduced production costs. The net income rose to $939,065 compared to $660,115 in 2020. The company also enhanced its cash position, with $1.47 million in cash and equivalents, compared to $643,000 in 2020. Reflect Scientific has returned to fully reporting status with the SEC and uplisted to OTCQB for better access to capital.
Reflect Scientific, Inc. (RSCF), a leader in biotechnology and transportation technologies, reported strong sales and profitability, driven by robust demand for blast freezers and chillers. The company successfully uplisted to the OTC QB, enhancing visibility and investor confidence. With a pending patent for HFC-free refrigeration solutions, Reflect Scientific aims to support green initiatives amid federal efforts to reduce greenhouse gas emissions. Their innovative technology also targets cold chain management and applications in diverse industries, including Bitcoin mining.
Reflect Scientific, Inc. (OTCQB: RSCF) reported its third-quarter financial results for 2021, highlighting a revenue increase to $716,145 compared to $610,085 the previous year. Gross profit also rose to $473,802 from $357,973 in Q3 2020, demonstrating improved margins in their cryogenic product line. The company's operating income stood at $159,889, indicating continued profitability despite market uncertainties. CEO Mr. Boyce emphasized the firm’s resilience in delivering products and maintaining positive financial outcomes.
Reflect Scientific, Inc. (RSCF) announced its successful up-listing to OTCQB effective October 28, 2021. This move aims to enhance investor access and support the company’s growth strategy. The OTCQB operates under the OTC Markets Group and is tailored for emerging companies, requiring current reporting and management certification. This listing is recognized by the SEC and allows for greater public information to aid investor analysis. Reflect Scientific develops innovative cryogenic cooling technologies for multiple industries, including biotechnology and pharmaceuticals.
Reflect Scientific, Inc. (Symbol: RSCF) announced its uplisting to the OTCQB Venture Market, enhancing its capital access and market visibility. CEO Kim Boyce emphasized that this strategic move aligns with the company’s growth plans in the cryogenic refrigeration sector. Reflect Scientific specializes in innovative cryogenic cooling technologies, primarily for the biotechnology and pharmaceutical industries. The uplisting is expected to facilitate future growth and acquisitions as the company expands its presence in the market.